Stay updated on LN-144 in Metastatic Uveal Melanoma Clinical Trial
Sign up to get notified when there's something new on the LN-144 in Metastatic Uveal Melanoma Clinical Trial page.

Latest updates to the LN-144 in Metastatic Uveal Melanoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedLocations were updated by adding a New York site and removing the prior New York Locations entry (v3.3.3); the HHS Vulnerability Disclosure link was removed from the footer.SummaryDifference0.2%

- Check22 days agoNo Change Detected
- Check29 days agoNo Change Detected
- Check43 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.2.0 was removed on the page, reflecting a backend/version update rather than a modification to study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check50 days agoChange DetectedAdded study record update dates (2025-11-13, 2025-11-12, 2025-11) and removed the government funding status notice.SummaryDifference0.6%

- Check65 days agoChange DetectedMinor UI and layout adjustments were made, with no changes to core study information (eligibility criteria, endpoints, enrollment, or locations). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check72 days agoChange DetectedThe label 'Last Update Posted' on the Study Details page is updated to 'Last Update Posted (Estimated)'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check93 days agoChange DetectedNew operating-status notice and v3.2.0 release; prior v3.1.0 revision removed.SummaryDifference3%

Stay in the know with updates to LN-144 in Metastatic Uveal Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LN-144 in Metastatic Uveal Melanoma Clinical Trial page.